Bassam Atallah, PharmD (@batallah08) 's Twitter Profile
Bassam Atallah, PharmD

@batallah08

Clinical Associate Professor and Senior Cardiology Pharmacotherapy Specialist - Cleveland Clinic Lerner College of Medicine and Cleveland Clinic Abu Dhabi

ID: 2176667365

calendar_today05-11-2013 19:22:02

1,1K Tweet

481 Takipçi

413 Takip Edilen

Ruth Masterson Creber PhD, RN, FAHA, FAAN (@ruthmcreber) 's Twitter Profile Photo

It was such a privilege to participate in this #AHA2024 panel today with Colleen McIlvennan @BidwellJ Bassam Atallah, PharmD addressing GDMT, patient-provider dyads, managing frailty in heart failure & overcoming systemic barriers to #teleheath. Cardiovascular and Stroke Nursing

It was such a privilege to participate in this #AHA2024 panel today with <a href="/colleenkmac/">Colleen McIlvennan</a> @BidwellJ <a href="/batallah08/">Bassam Atallah, PharmD</a> addressing GDMT, patient-provider dyads, managing frailty in heart failure &amp; overcoming systemic barriers to #teleheath. <a href="/CVSNHeart/">Cardiovascular and Stroke Nursing</a>
Bassam Atallah, PharmD (@batallah08) 's Twitter Profile Photo

Scientific sessions at the 100th Anniversary of the AHA Science in Chicago #AHA2024 Honored to Present on “Role of a Pharmacist in Outpatient Optimization of GDMT” sharing our own experience in establishing the first pharmacist led pharmacotherapy optimization clinic at Cleveland Clinic Abu Dhabi

Scientific sessions at the 100th Anniversary of the <a href="/AHAScience/">AHA Science</a> in Chicago #AHA2024 

Honored to Present on “Role of a Pharmacist in Outpatient Optimization of GDMT” sharing our own experience in establishing the first pharmacist led pharmacotherapy optimization clinic at <a href="/CCAD/">Cleveland Clinic Abu Dhabi</a>
Circulation (@circaha) 's Twitter Profile Photo

#CircAHA24 PE Trial: Longer anticoagulation therapy (rivaroxaban for 18 months) had a benefit in patients with cancer and acute low-risk pulmonary embolism compared to shorter 6-month treatment. Yuji Nishimoto 小板橋紀通 Nori Koitabashi ahajrnls.org/3UYD9Hz

#CircAHA24 PE Trial: Longer anticoagulation therapy (rivaroxaban for 18 months) had a benefit in patients with cancer and acute low-risk pulmonary embolism compared to shorter 6-month treatment. <a href="/saipon_yuji/">Yuji Nishimoto</a> <a href="/GunmaUnivNKoita/">小板橋紀通 Nori Koitabashi</a> ahajrnls.org/3UYD9Hz
Bassam Atallah, PharmD (@batallah08) 's Twitter Profile Photo

Screening and treatment of iron deficiency among heart failure patients with impaired ejection fraction: The impact of a pharmacist‐led protocol - Alaryani - JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY - Wiley Online Library accpjournals.onlinelibrary.wiley.com/doi/full/10.10…

ACCP (@accp) 's Twitter Profile Photo

Congratulations to ACCP member Bassam Atallah and co-authors on the recent publication of their article in JACCP! Access the abstract and/or article here: ow.ly/1xGc50Vk7QC JACCP #OpenAccess #MakingAnImpact #ACCP

Congratulations to ACCP member Bassam Atallah and co-authors on the recent publication of their article in JACCP! Access the abstract and/or article here: ow.ly/1xGc50Vk7QC

<a href="/JACCPJournal/">JACCP</a> #OpenAccess #MakingAnImpact #ACCP
NEJM (@nejm) 's Twitter Profile Photo

Original Article: Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism (API-CAT) nej.md/41YkRZK Editorial: Cancer-Associated Venous Thromboembolism — Beyond 6 Months nej.md/4iB6wcA #Cardiology

Original Article: Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism (API-CAT) nej.md/41YkRZK 

Editorial: Cancer-Associated Venous Thromboembolism — Beyond 6 Months nej.md/4iB6wcA 

#Cardiology
ISCP / International Society of CV Pharmacotherapy (@iscpcardio) 's Twitter Profile Photo

🎤 Meet Dr. Bassam Atallah – Our Featured Speaker Join Dr. Atallah (UAE) on July 23 as he walks us through pharmacologic innovations in HCM care—from classic medications to emerging myosin inhibitors. With a decade of clinical and academic experience, Dr. Atallah brings a

🎤 Meet Dr. Bassam Atallah – Our Featured Speaker
Join Dr. Atallah (UAE) on July 23 as he walks us through pharmacologic innovations in HCM care—from classic medications to emerging myosin inhibitors.

With a decade of clinical and academic experience, Dr. Atallah brings a
JACC Journals (@jaccjournals) 's Twitter Profile Photo

In frail, elderly #AFib patients previously on a vitamin K antagonist, switching to standard-dose direct-acting oral anticoagulant reduced stroke, fatal/intracranial bleeding, and death, despite more GI bleeding. jacc.org/doi/10.1016/j.… #JACC #DOAC

In frail, elderly #AFib patients previously on a vitamin K antagonist, switching to standard-dose direct-acting oral anticoagulant reduced stroke, fatal/intracranial bleeding, and death, despite more GI bleeding. jacc.org/doi/10.1016/j.… #JACC #DOAC
JAMA Cardiology (@jamacardio) 's Twitter Profile Photo

AFIRE RCT: Rivaroxaban monotherapy yielded a consistent net clinical benefit across all age groups, especially in older patients with atrial fibrillation and stable coronary artery disease. ja.ma/3Jcoa9T

AFIRE RCT: Rivaroxaban monotherapy yielded a consistent net clinical benefit across all age groups, especially in older patients with atrial fibrillation and stable coronary artery disease. ja.ma/3Jcoa9T
JAMA Cardiology (@jamacardio) 's Twitter Profile Photo

Finerenone reduced the need for loop diuretic dose intensification and lowered the average loop diuretic dose across all diuretic subgroups in patients with HFmrEF/HFpEF. ja.ma/4meRfzV

Finerenone reduced the need for loop diuretic dose intensification and lowered the average loop diuretic dose across all diuretic subgroups in patients with HFmrEF/HFpEF. 

ja.ma/4meRfzV
JACC Journals (@jaccjournals) 's Twitter Profile Photo

🫀 In familial hypercholesterolemia (HeFH), artery changes start young—carotid plaque at 17♂ / 30♀, coronary plaque at 26♂ / 36♀. Triple checks 🩻 (carotid, coronary, CAC) improve risk stratification & prevention 💪 Full study 👉 jacc.org/doi/10.1016/j.… #JACCAsia #cvPrev

🫀 In familial hypercholesterolemia (HeFH), artery changes start young—carotid plaque at 17♂ / 30♀, coronary plaque at 26♂ / 36♀. Triple checks 🩻 (carotid, coronary, CAC) improve risk stratification &amp; prevention 💪 Full study 👉 jacc.org/doi/10.1016/j.…  #JACCAsia #cvPrev
Adrian da Silva (@adrianjdasilva) 's Twitter Profile Photo

New in JACC HF: #Transferrin Saturation Is a Better Predictor Than Ferritin of Metabolic and Hemodynamic Exercise Responses in #HFpEF shorturl.at/pknri

New in JACC HF:

#Transferrin Saturation Is a Better Predictor Than Ferritin of Metabolic and Hemodynamic Exercise Responses in #HFpEF

shorturl.at/pknri
American College of Cardiology (@accintouch) 's Twitter Profile Photo

ICYMI: A new ACC/AHA Scientific Statement introduces the PREVENT risk calculator & details the supporting evidence & rationale behind its use. Learn more: bit.ly/41xhycz #hypertension JACC Journals

ICYMI: A new ACC/AHA Scientific Statement introduces the PREVENT risk calculator &amp; details the supporting evidence &amp; rationale behind its use.

Learn more: bit.ly/41xhycz #hypertension <a href="/JACCJournals/">JACC Journals</a>
American College of Cardiology (@accintouch) 's Twitter Profile Photo

ACC’s #FamilialHypercholesterolemia online course will keep you up to date on the latest tools & techniques to recognize HoFH & HeFH – a life-changing diagnosis that provides access to early treatment options. More ➡️ bit.ly/3vNLMqW #ACCEd #CholesterolEducationMonth

ACC’s #FamilialHypercholesterolemia online course will keep you up to date on the latest tools &amp; techniques to recognize HoFH &amp; HeFH – a life-changing diagnosis that provides access to early treatment options. More ➡️ bit.ly/3vNLMqW

 #ACCEd #CholesterolEducationMonth
ECS_heart (@ecs_heart) 's Twitter Profile Photo

A messege from Dr Bassam Atallah: "On #WorldPharmacistsDay, we recognize the crucial role pharmacists play in advancing safe, effective, and evidence-based cardiac care. Thank you for your dedication to patients’ health." #EmiratesCardiacSociety #ECS Bassam Atallah, PharmD